BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26139420)

  • 1. Long-term follow-up of the risk for cervical intraepithelial neoplasia grade 2 or worse in HPV-negative women after conization.
    Gosvig CF; Huusom LD; Andersen KK; Duun-Henriksen AK; Frederiksen K; Iftner A; Svare E; Iftner T; Kjaer SK
    Int J Cancer; 2015 Dec; 137(12):2927-33. PubMed ID: 26139420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of human papillomavirus testing and cytology in follow-up after conization.
    Gosvig CF; Huusom LD; Deltour I; Andersen KK; Duun-Henriksen AK; Madsen EM; Petersen LK; Elving L; Schouenbourg L; Iftner A; Svare E; Iftner T; Kjaer SK
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):405-11. PubMed ID: 25645089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade CIN on cervical biopsy and predictors of the subsequent cone histology results in women undergoing immediate conization.
    Giannella L; Mfuta K; Gardini G; Rubino T; Fodero C; Prandi S
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():68-74. PubMed ID: 25656975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific predictors of cervical dysplasia recurrence after primary conization: analysis of 3,212 women.
    Bogani G; Pinelli C; Chiappa V; Martinelli F; Lopez S; Ditto A; Raspagliesi F
    J Gynecol Oncol; 2020 Sep; 31(5):e60. PubMed ID: 32808492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
    Spinillo A; Dominoni M; Boschi AC; Cesari S; Fiandrino G; Gardella B
    Gynecol Oncol; 2020 Dec; 159(3):630-635. PubMed ID: 33041069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of recurrent disease following conization of cervical intraepithelial neoplasia grade 3 according to post-conization HPV status and surgical margins.
    Sand FL; Frederiksen K; Kjaer SK
    Gynecol Oncol; 2022 Jun; 165(3):472-477. PubMed ID: 35400526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia.
    Huang HJ; Tung HJ; Yang LY; Chao A; Tang YH; Chou HH; Chang WY; Wu RC; Huang CC; Lin CY; Liao MJ; Chen WC; Lin CT; Chen MY; Huang KG; Wang CJ; Chang TC; Lai CH
    Int J Cancer; 2021 Feb; 148(3):665-672. PubMed ID: 32781482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
    BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway.
    Vintermyr OK; Iversen O; Thoresen S; Quint W; Molijn A; de Souza S; Rosillon D; Holl K
    Gynecol Oncol; 2014 May; 133(2):159-66. PubMed ID: 24631451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative post-conisation human papillomavirus testing for early detection of treatment failure in patients with cervical intraepithelial neoplasia: a pilot study.
    Torné A; Fusté P; Rodríguez-Carunchio L; Alonso I; del Pino M; Nonell R; Cardona M; Rodríguez A; Castillo P; Pahisa J; Balasch J; Ramírez J; Ordi J
    BJOG; 2013 Mar; 120(4):392-9. PubMed ID: 23189989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
    Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S
    Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up.
    Bar-Am A; Gamzu R; Levin I; Fainaru O; Niv J; Almog B
    Gynecol Oncol; 2003 Oct; 91(1):149-53. PubMed ID: 14529675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV Test as Test of Cure After Conization for CIN2+: A Nationwide Register-Based Cohort Study.
    Bruhn LV; Hyldig N; Schledermann D
    J Low Genit Tract Dis; 2022 Oct; 26(4):287-292. PubMed ID: 36126201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
    Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
    Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status.
    Sand FL; Kjaer SK; Frederiksen K; Dehlendorff C
    Int J Cancer; 2020 Aug; 147(3):641-647. PubMed ID: 31648368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of high-risk human papillomavirus (HPV) mRNA testing in the prediction of residual disease after conisation for high-grade cervical intraepithelial neoplasia.
    Tropé A; Jonassen CM; Sjøborg KD; Nygård M; Dahl FA; Alfsen GC; Lie AK
    Gynecol Oncol; 2011 Nov; 123(2):257-62. PubMed ID: 21839500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV-testing versus HPV-cytology co-testing to predict the outcome after conization.
    Bruhn LV; Andersen SJ; Hariri J
    Acta Obstet Gynecol Scand; 2018 Jun; 97(6):758-765. PubMed ID: 29430635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study.
    Bogani G; DI Donato V; Sopracordevole F; Ciavattini A; Ghelardi A; Lopez S; Simoncini T; Plotti F; Casarin J; Serati M; Pinelli C; Valenti G; Bergamini A; Gardella B; Dell'acqua A; Monti E; Vercellini P; Fischetti M; D'Ippolito G; Aguzzoli L; Mandato VD; Carunchio P; Carlinfante G; Giannella L; Scaffa C; Falcone F; Borghi C; Ditto A; Malzoni M; Giannini A; Salerno MG; Liberale V; Contino B; Donfrancesco C; Desiato M; Perrone AM; Dondi G; De Iaco P; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Ferrero S; Sarpietro G; Matarazzo MG; Cianci A; Bosio S; Ruisi S; Guerrisi R; Brusadelli C; Mosca L; Tinelli R; DE Vincenzo R; Zannoni GF; Ferrandina G; Petrillo M; Dessole S; Angioli R; Greggi S; Spinillo A; Ghezzi F; Colacurci N; Muzii L; Benedetti Panici P; Scambia G; Raspagliesi F
    Gynecol Oncol; 2020 Dec; 159(3):636-641. PubMed ID: 32893030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of high-risk HPV persistence after laser CO2 conization for high-grade CIN: a prospective clinical study.
    Fallani MG; Penna C; Marchionni M; Bussani C; Pieralli A; Andersson KL; Fambrini M
    Eur J Gynaecol Oncol; 2008; 29(4):378-82. PubMed ID: 18714574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.